It has been reported to promote GBM cell proliferation and self-renewal by enhancing Myc binding to coactivator-associated arginine methyltransferase 1 (CARM1), thereby upregulating oncogene CARM1 expression [231]. This evidence concerns the gene CARM1 and glioblastoma.